ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1354

Ultrasound Verified Inflammation and Structural Abnormalities in Patients with Hemochromatosis with and without Associated Arthropathy

Christian Dejaco1, Andreas Stadlmayr2, Viktoria Trimmel3, Christina Duftner4, Rusmir Husic1, Elisabeth Krones5, Shahin Zhandieh6, Emma Husar-Memmer7, Gernot Zollner8, Josef Hermann1, Judith Gretler1, Angelika Lackner1, Anja Ficjan1, Christian Datz2, Roland Axmann7 and Jochen Zwerina9, 1Rheumatology and Immunology, Medical University Graz, Graz, Austria, 2Internal Medicine, General Hospital Oberndorf, Oberndorf, Austria, 3Radiology, Medical University Graz, Graz, Austria, 4Medical University Innsbruck, Innsbruck, Austria, 5Gastroenterology and Hepatology, Medical University Graz, Graz, Austria, 6Radiology, Hanusch Hospital, Vienna, Austria, 7First Department of Internal Medicine, Hanusch Hospital, Vienna, Austria, 8Gastroenterology, Medical University Graz, Graz, Austria, 9First Department of Internal Medicine and Ludwig Bolzmann Institute of Osteology, Hanusch Hospital, Vienna, Austria

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Hemochromatosis, osteoarthritis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  To study inflammatory and structural ultrasound lesions in patients with hereditary hemochromatosis (HH) with and without arthropathy

Methods:   Cross-sectional study of 50 patients with HH [mean age 57.5 (±SD 11.6) years years, 26.0% female, median disease duration 8.8 (range 0.8-27.6) years] recruited at medical centers in Graz, Oberndorf and Vienna. HH arthropathy (HH-A) was defined as the presence of hand pain (VAS>10mm and/or ≥1 tender joint) plus ≥1 radiographic finding compatible with HH-A. Thirty-eight patients with hand osteoarthritis (HOA, according to ACR criteria) were studied for comparison [mean age, 60.1 (±SD 9.4), 89.5% female). Clinical examination was performed at 68 joints, and we retrieved data on hand function, pain and overall health status (all using a VAS), morning stiffness, ferritin levels and phlebotomy. Ultrasound was conducted at 40 joints (hand joints, hips, knees, ankles) by one rheumatologist blinded to clinical data using an ESAOTE Twice ultrasound device. Synovial hypertrophy and/or joint effusion (SH/E), Power Doppler (PD), osteophytes and erosions were subjectively graded from 0 to 3 in accordance with prior publications.

Results: Twenty-six (52.0%) HH patients were classified as HH-A. Mean age [57.1 (±SD 13.0) vs. 57.8 (±SD 9.7) years], median disease duration [7.5 (3.2-22.8) vs. 10.3 (0.8-27.6) years), median ferritin levels [83.6 (23-1060) vs. 66.1 ng/ml (14-853) as well as median duration [6.0 (0-23) vs. 6.0 (0-26) years] and number of phlebotomies/year [3 (0-5) vs. (2.5 (0-12)] were comparable between HH patients Without Arthropathy (HH-WA) and HH-A patients.<span”>Patients with HH-A and HOA had a similar number of tender [4 (0-29) vs. 3 (0-40)] and swollen joints [0 (0-7) vs. 0 (0-6)], and similar scores for hand function [39.5 (0-100) vs. 47.0 (0-92) mm] and hand pain [31.0 (0-72) vs. 23.0 (0-86) mm]. These findings were absent/low in HH-WA patients by definition.Using ultrasound, we observed ≥1 erosion in 10 (41.7%) HH-WA patients, 12 (46.2%) HH-A, and 21 (55.3) HOA patients (p>0.2). Similarly, ≥1 osteophyte was observed in 23 (95.8%), 26 (100%) and 38 (100%) patients, respectively (p>0.2); median osteophyte score, however, was higher in HH-A than in HH-WA patients [19 (0-53) vs. 30 (3-69), p=0.019] and comparable between HH-A and HOA [36 (8-68)]. SH/E were observed in a high portion of HH-WA, HH-A and HOA patients [20 (83.3%), 25 (96.2%) and 38 (100%), respectively] whereas PD-findings were more common in the HH-A [n=21 (80.8%)] and the HOA [n=31 (81.6%)] than in the HH-WA group [n=12 (50.0%), p<0.05]. Also, SH/E scores were comparable between the three groups [HH-WA: 6.5 (0-25), HH-A 9 (0-32) and HOA 11.5 (1-30)] whereas PD-scores were higher in HH-A [2.5 (0-17] and HOA [2 (0-17] than in HH-WA cases [0.5 (0-9), p<0.05). In HH-A patients, there was a weak correlation between PD-score and hand function (0.23, p=0.031), whereas the other clinical parameters were unrelated to ultrasound results.

Conclusion:  A high prevalence of ultrasound verified inflammatory and structural lesions were found in patients with hereditary hemochromatosis. Higher PD scores were observed in patients with arthropathy, and these were related to limited hand function.


Disclosure: C. Dejaco, None; A. Stadlmayr, None; V. Trimmel, None; C. Duftner, None; R. Husic, None; E. Krones, None; S. Zhandieh, None; E. Husar-Memmer, None; G. Zollner, None; J. Hermann, None; J. Gretler, None; A. Lackner, None; A. Ficjan, None; C. Datz, None; R. Axmann, None; J. Zwerina, None.

To cite this abstract in AMA style:

Dejaco C, Stadlmayr A, Trimmel V, Duftner C, Husic R, Krones E, Zhandieh S, Husar-Memmer E, Zollner G, Hermann J, Gretler J, Lackner A, Ficjan A, Datz C, Axmann R, Zwerina J. Ultrasound Verified Inflammation and Structural Abnormalities in Patients with Hemochromatosis with and without Associated Arthropathy [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/ultrasound-verified-inflammation-and-structural-abnormalities-in-patients-with-hemochromatosis-with-and-without-associated-arthropathy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-verified-inflammation-and-structural-abnormalities-in-patients-with-hemochromatosis-with-and-without-associated-arthropathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology